Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection

Clalit Health Services

Status and phase: Withdrawn; Phase 4

Conditions: Urinary Tract Infection

Treatments: Drug: Hyaluronic Acid

Study type: Interventional

Funder types: Other

Identifiers

NCT02034890

RMC-7350

Details and patient eligibility

About

Prospective trial which includes instillation of intravesical hyaluronic acid in an attempt to reduce the incidence of urinary tract infections in patients after orthotopic neobladder reconstruction.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients undergoing radical cystectomy and orthotopic neobladder reconstruction

Exclusion criteria

• patients <18 years and unwilling to participate in this study

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

hyaluronic acid

Experimental group

Description:

intravesical instillation of 40 mg of hyaluronic acid at 6 specific time points: 1,2,3 and 4 weeks postoperatively 2 and 3 months postoperatively

Treatment:

Drug: Hyaluronic Acid

retrospective control patients

No Intervention group

Description:

retrospective control patients